Good binocular results in children with early-onset exotropia

Article

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

A research team led by Dr S. Y. Suh, Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, examined the medical records of 45 exotropia patients with a reported onset before one year of age. All patients were operated on between 2008 and 2011 and clinical characteristics and surgical outcomes were analysed retrospectively.

Patients were divided into either a constant exotropia group (XT) or and intermittent group (X(T)). The team compared clinical features and surgical results of exotropia between the two groups. The mean age at surgery was 4.5±2.4 years and the mean postoperative follow-up period was 17.3 months.

Of the total patients reviewed, 67% demonstrated an alignment of less than ±10 prism diopters (PD) at the final visit. In all 34 testable patients, gross stereopsis was achieved and bifixation was developed in 10 patients. There were no significant differences between the groups with regards to surgical success rates and binocularities.

Both motor and sensory surgical outcomes were not poor in early-onset exotropia patients, even in those with constant deviation.

The abstract can be read here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.